Clinical Trials Browser

Phase 2 × pazopanib × Plasma cell × Clear all

NCT00256880 2017-01-18

Pazopanib (GW786034) In Subjects With Relapsed Or Refractory Multiple Myeloma

Phase 2 Completed

GenitourinaryPlasma cell

Carcinoma, Renal Cell, Neoplasms, Plasma Cell